Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

Read more

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Read more

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Read more

AstraZeneca, YMCA Launch National Cancer Education Partnership

Read more

Antares, Novartis Partner on Cancer Drug Discovery

Read more

FDA Approves TRYNGOLZA for Severe Hypertriglyceridemia

Read more

RQ Bio Raises $115 Million for Influenza Antibody Therapy

Read more

EU Approves KEYTRUDA-Padcev for Bladder Cancer

Read more

Merck to Acquire Bio-Techne in $11.3 Billion Deal

Read more

Ionis, Recordati Partner to Expand Zilganersen Access Globally

Read more